Planning and monitoring of patients for electrical cardioversion for atrial fibrillation

Netherlands Heart Journal

Volumn 20, Issue 4, 2012, Pages 148-154

  Deuling, J H H ^a   Vermeulen, R P ^a   Smit, M D ^a   van der Maaten, J M A A ^a   Boersema, H M ^a   van den Heuvel, A F M ^a   van Gelder, I C ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Electrical cardioversion; INR monitoring; Nurse practitioner

Indexed keywords

AMIODARONE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVERSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; OBSERVATIONAL STUDY; PATIENT MONITORING; PHYSICIAN; PROSPECTIVE STUDY; SINUS RHYTHM; THERAPY DELAY; THROMBOEMBOLISM;

EID: 84859642100     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0208-z     Document Type: Article

References (18)

1. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347(23):1834-40.
2. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825-33.
3. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429.
4. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation. American Heart Association/American College of Cardiology. Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003;41(9):1633-52.
5. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360-420.
6. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68(1):41-6.
7. Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996;156(22):2585-92.
8. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med. 2005;45(4):347-53.
9. Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376 (9745):975-83.
10. Veeger NJ, Piersma-Wichers M, Tijssen JG, et al. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol. 2005;128(4):513-9.
11. Matchar DB, Jacobson A, Dolor R, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608-20.
12. Channer KS, Birchall A, Steeds RP, et al. A randomized placebo-controlled trial of pre-treatment and short- or longterm maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. Eur Heart J. 2004;25(2):144-50.
13. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-51.
14. Nagarakanti R, Ezekowitz MD, Oldgren J, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011;123(2):131-6.
15. Verheugt FW. The new oral anticoagulants. Neth Heart J. 2010;18 (6):314-8.
16. Tieleman RG, Gosselink AT, Crijns HJ, et al. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol. 1997;79(1):53-7.
17. Hendriks JL, Nieuwlaat R, Vrijhoef HJ, et al. Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program. Neth Heart J. 2010;18(10):471-7.
18. Shelton RJ, Allinson A, Johnson T, et al. Four years experience of a nurse-led elective cardioversion service within a district general hospital setting. Europace. 2006;8(1):81-5.